{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:24:26Z","timestamp":1790666666754,"version":"4.1.0"},"reference-count":47,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Cannabis use disorder (CUD) is one of the most common substance use disorders (SUDs) worldwide and is frequently associated with high rates of polysubstance use; however, despite rising rates of polysubstance use disorders (PUD), the characteristics of individuals with both CUD and PUD remain unclear. This study, therefore, aims to examine social and clinical characteristics of adults diagnosed with CUD and comorbid PUD. It also aims to assess whether psychiatric disorders are linked to higher odds of PUD among individuals with CUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using a nationally representative U.S. dataset, we assessed 972 individuals with past-year DSM-5 CUD, grouped as CUD only, CUD individuals with one additional SUD (CUD + 1), and CUD individuals with two or more SUDs (CUD + 2). Descriptive statistics summarized social and clinical presentations; multivariate logistic regression examined factors contributing to PUD, controlling for clinical diagnoses and childhood maltreatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among CUD individuals, 89.3% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 868) used at least one other substance in the past year, with 34.2% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 332) using two or more. Both the CUD + 1 and CUD + 2 groups experienced significantly more severe childhood maltreatment than CUD only. After adjusting for controls, personality disorders were associated with membership in the CUD + 1 group (odds ratio [OR]: 1.88,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.01); mood disorders were associated with a higher likelihood of being in the CUD + 1 group (OR: 1.50,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.049) and CUD + 2 group (OR: 2.58,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mood and personality disorders were highly prevalent and linked with PUD in CUD cases. We recommend screening for these disorders in complex CUD cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/25785125251363122","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:41Z","timestamp":1759248101000},"page":"170-179","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Polysubstance Use Disorders in Individuals with Cannabis Use Disorder: Results from a Nationally Representative Sample (National Epidemiologic Survey on Alcohol and Related Conditions)"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-1626","authenticated-orcid":false,"given":"Linas","family":"Wilkialis","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9102-5814","authenticated-orcid":false,"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada."},{"name":"Department of Psychiatry and Behavioural Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-1858","authenticated-orcid":false,"given":"Ahmed Nabeel","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada."},{"name":"Department of Psychiatry, Department of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia."},{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada."},{"name":"Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-4973","authenticated-orcid":false,"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada."},{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada."},{"name":"Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00569"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abrep.2019.100189"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2132"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.02.014"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.04.012"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0886260517715024"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.14053"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.009"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15070907"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.06.004"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205701105"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.093062"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.3.564"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.05.015"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105873"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chiabu.2015.07.014"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.01.031"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2018.100144"},{"key":"e_1_3_6_20_2","volume-title":"National Institute on Alcohol Abuse and Alcoholism National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) Source and Accuracy Statement","author":"Grant BF","year":"2014","unstructured":"Grant BF, , Chu A, , Sigman R, et al. National Institute on Alcohol Abuse and Alcoholism National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) Source and Accuracy Statement. National Institute on Alcohol Abuse and Alcoholism: Rockville, MD; 2014."},{"key":"e_1_3_6_21_2","volume-title":"Bureau of the Census: American Community Survey, 2012","author":"Anonymous","year":"2013","unstructured":"Anonymous. Bureau of the Census: American Community Survey, 2012. U.S. Census Bureau: Suitland, Maryland; 2013."},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.11.026"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000069"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.12.003"},{"key":"e_1_3_6_25_2","volume-title":"U.S. Alcohol Epidemiologic Data Reference Manual, Volume 10","author":"Chen CM","year":"2016","unstructured":"Chen CM, , Slater ME, , Castle I-JP, et al. Alcohol use and alcohol use disorders in the United States: Main Findings from the 2012\u20132013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). U.S. Alcohol Epidemiologic Data Reference Manual, Volume 10. National Institute on Alcohol Abuse and Alcoholism (NIAAA): Bethesda, MD; 2016."},{"key":"e_1_3_6_26_2","volume-title":"National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) Data Notes","author":"Anonymous","unstructured":"Anonymous. National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) Data Notes. National Institute on Alcohol Abuse and Alcoholism (NIAAA); n.d."},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.2307\/351733"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.8.1132"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.06.001"},{"key":"e_1_3_6_30_2","unstructured":"Anonymous. IBM SPSS Statistics 29.0. 2023."},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108222"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.14547"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2022.2040029"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2024.108136"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20180037"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2013.07.012"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04160-2"},{"issue":"1","key":"e_1_3_6_38_2","first-page":"11","article-title":"Alcohol and cannabis use and the developing brain","volume":"41","author":"Lees B","year":"2021","unstructured":"Lees B, , Debenham J, , Squeglia LM. Alcohol and cannabis use and the developing brain. Alcohol Res, 2021; 41(1):11; doi: 10.35946\/arcr.v41.1.11","journal-title":"Alcohol Res"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2022.208942"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.014"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110570"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0011-2"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12425"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211054740"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2017.05.004"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.8.807"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n0211"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30337-7"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/25785125251363122","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/25785125251363122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/25785125251363122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:22:08Z","timestamp":1787131328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/25785125251363122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,1]]}},"alternative-id":["10.1177\/25785125251363122"],"URL":"https:\/\/doi.org\/10.1177\/25785125251363122","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}